Package 62756-299-13

{"route": ["ORAL"], "spl_id": "c89dfc75-606c-4a4e-9d2b-d907b492a837", "openfda": {"upc": ["0362756432833"], "unii": ["4182431BJH"], "rxcui": ["855861", "855873"], "spl_set_id": ["c40f66cc-6f4a-4b29-84ba-d265e4848735"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-08)", "package_ndc": "62756-299-08", "marketing_start_date": "20080630"}, {"sample": false, "description": "500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-13)", "package_ndc": "62756-299-13", "marketing_start_date": "20080630"}, {"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-83)", "package_ndc": "62756-299-83", "marketing_start_date": "20080630"}, {"sample": false, "description": "100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (62756-299-88)", "package_ndc": "62756-299-88", "marketing_start_date": "20080630"}], "brand_name": "phenytoin sodium", "product_id": "62756-299_c89dfc75-606c-4a4e-9d2b-d907b492a837", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "62756-299", "generic_name": "phenytoin sodium", "labeler_name": "Sun Pharmaceutical Industries, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "phenytoin sodium", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "200 mg/1"}], "application_number": "ANDA040731", "marketing_category": "ANDA", "marketing_start_date": "20080630", "listing_expiration_date": "20261231"}